Use of Technetium‐99m‐Pyrophosphate Single‐Photon Emission Computed Tomography/Computed Tomography in Monitoring Therapeutic Changes of Eplontersen in Patients With Hereditary Transthyretin Amyloid Cardiomyopathy

Use of Technetium‐99m‐Pyrophosphate Single‐Photon Emission Computed Tomography/Computed Tomography in Monitoring Therapeutic Changes of Eplontersen in Patients With Hereditary Transthyretin Amyloid Cardiomyopathy

Background Hereditary transthyretin amyloid cardiomyopathy (hATTR‐CM) is a progressive and fatal disease. Recent evidence indicates that bone scintigraphy may serve as a tool to monitor the effectiveness of hATTR‐CM treatment. The objective of this study was to examine how eplontersen therapy influe...

Full description

Bibliographic Details
Main Authors: An‐Li Yu, Yi‐Chieh Chen, Cheng‐Hsuan Tsai, Yuan‐Kun Aden Wu, Mao‐Yuan Su, Chia‐Hung Chou, Chia‐Tung Shun, Hsueh‐Wen Hsueh, Jimmy Jyh‐Ming Juang, Ming‐Jen Lee, Ping‐Huei Tseng, Chia‐Hua Hsu, Sung‐Tsang Hsieh, Chi‐Lun Ko, Mei‐Fang Cheng, Chi‐Chao Chao, Yen‐Hung Lin
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
99mTc‐pyrophosphate
eplontersen
hereditary transthyretin amyloidosis
single‐photon emission computed tomography/computed tomography
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.030512

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.123.030512

Similar Items